Vancouver, British Columbia–(Newsfile Corp. – May 21, 2025) – Stardust Solar Energy Inc. (TSXV: SUN) (OTCQB: SUNXF) today announced that it has executed a definitive partnership agreement with B2B Solar Solutions to launch a dedicated warehousing, logistics, and fulfillment centre in Owen Sound, Ontario. The new facility provides a central …
Read More »Grape Law’s Remarkable Growth Makes It the 5th Fastest-Growing Firm in the U.S. Northeast
Grape Law’s two-year growth rate of 1,178% places it among the top five fastest-growing private firms in the U.S. Northeast. The ranking on Inc.’s 2025 Regionals: Northeast list reflects the firm’s innovative legal-tech platforms, client-centric service model, and significant contribution to regional job creation and economic expansion. New York, New …
Read More »BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound
First CDMO Project to Utilize In-house AI Tools for Discovery of Plant Cell Targets for the Botanical Synthesis Process Rehovot, Israel–(Newsfile Corp. – May 21, 2025) – BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) (“BioHarvest” or the “Company”), a company pioneering its patented Botanical Synthesis technology platform, today announced that …
Read More »Turnium Technology Group Reports 60.1% YoY Revenue Growth for Fiscal Q2 2025
Highlights: Q2 Revenue of $2.19M and Q2 Gross Margin of $1.28MQ2 Operating Expenses of $1.37M vs $2.82M QoQ – a 51% sequential reductionPositive Adjusted EDITDA of $0.1M in Q2 – ahead of scheduleGuidance for Q3 FY2025, ending June 30, 2025: the Company expects Revenue of $2.5M to $2.75M, and Gross …
Read More »Western Gold Announces a $850,050 Closing for Previously Announced Non-Brokered Private Placement and Increase in Size of the Private Placement
North Berwick, Scotland–(Newsfile Corp. – May 21, 2025) – WESTERN GOLD EXPLORATION LTD. (TSXV: WGLD) (the “Company”) is pleased to announce a closing of its previously announced non-brokered private placement for aggregate gross proceeds of CAD$850,050 (the “Private Placement”). In connection with this closing of the Private Placement, on May …
Read More »Hercules Metals Commences 2025 Drilling Program at the Hercules Project
Toronto, Ontario–(Newsfile Corp. – May 21, 2025) – Hercules Metals Corp. (TSXV: BIG) (OTCQB: BADEF) (FSE: C0X) (“Hercules” or the “Company”) is pleased to announce that its 2025 drilling campaign is now underway at the Hercules Project in western Idaho (the “Property”). Two core drilling rigs are currently operating, with …
Read More »Indigo Exploration Inc. Announces Name Change to Noble Plains Uranium Corp.
Vancouver, British Columbia–(Newsfile Corp. – May 21, 2025) – Indigo Exploration Inc. (TSXV: IXI) (OTCQB: IXIXF) (FSE: INE) (the “Company”) announces that it will be changing its name from “Indigo Exploration Inc.” to “Noble Plains Uranium Corp.”, a step that reflects the Company’s strategic focus on uranium exploration and development …
Read More »Anteros Identifies High-Grade Copper-Gold Targets at the Strickland VMS Property, Newfoundland
St. John’s, Newfoundland and Labrador–(Newsfile Corp. – May 21, 2025) – Anteros Metals Inc. (CSE: ANT) (“Anteros” or the “Company”) is pleased to report results from recent assessment work at its 100% owned Strickland VMS Property (“Strickland” or the “Property”) in southwestern Newfoundland. The work focused on the digitization and …
Read More »Dexterra Announces Renewal of Normal Course Issuer Bid
Toronto, Ontario–(Newsfile Corp. – May 21, 2025) – Dexterra Group Inc. (TSX: DXT) (“Dexterra”) is pleased to announce that the Toronto Stock Exchange (“TSX”) has approved its notice of intention to renew its normal course issuer bid (“NCIB”). Pursuant to the terms of the NCIB, commencing on May 23, 2025 …
Read More »NervGen Pharma to Present Topline Data for NVG-291 Phase 1b/2a Chronic Cohort Study at the American Spinal Injury Association Annual Scientific Meeting
Vancouver, British Columbia–(Newsfile Corp. – May 21, 2025) – NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotechnology company dedicated to developing neuroreparative therapeutics, today announced that topline results from the chronic cohort of the ongoing Phase 1b/2a study of NVG-291 will be presented as an oral presentation at …
Read More »
Matribhumi Samachar English